Net Cash Provided by (Used in) Financing Activities in USD of Biostax Corp. from 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biostax Corp. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2012 to Q1 2024.
  • Biostax Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $5,624, a 96% decline year-over-year.
  • Biostax Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $287,320, a 61% decline from 2022.
  • Biostax Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $738,427, a 3.2% increase from 2021.
  • Biostax Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $715,631, a 263% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Biostax Corp. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $5,624 -$144,376 -96% 01 Jan 2024 31 Mar 2024 10-Q/A 19 Aug 2024 2024 Q1
Q1 2023 $150,000 01 Jan 2023 31 Mar 2023 10-Q/A 19 Aug 2024 2024 Q1
Q1 2018 $473,470 -$79,684 -14% 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019 2019 Q1
Q1 2017 $553,154 -$153,846 -22% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $707,000 +$111,025 +19% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q1 2015 $595,975 -$591,050 -50% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q1 2014 $1,187,025 -$20,632 -1.7% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $1,207,657 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1

Biostax Corp. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $287,320 -$451,107 -61% 01 Jan 2023 31 Dec 2023 10-K/A 05 Jul 2024 2023 FY
2022 $738,427 +$22,796 +3.2% 01 Jan 2022 31 Dec 2022 10-K/A 05 Jul 2024 2023 FY
2021 $715,631 +$518,631 +263% 01 Jan 2021 31 Dec 2021 10-K 10 Apr 2023 2022 FY
2020 $197,000 01 Jan 2020 31 Dec 2020 10-K 18 Mar 2022 2021 FY
2018 $1,362,615 -$632,482 -32% 01 Jan 2018 31 Dec 2018 10-K/A 28 Aug 2020 2019 FY
2017 $1,995,097 -$897,607 -31% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
2016 $2,892,704 +$229,229 +8.6% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $2,663,475 -$1,023,464 -28% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 $3,686,939 -$3,143,771 -46% 01 Jan 2014 31 Dec 2014 10-K/A 16 May 2016 2015 FY
2013 $6,830,710 +$5,608,082 +459% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $1,222,628 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.